Sponsors

Choosing your pathology partner: why wide experience counts

Using examples from Peterborough and Gateshead, Paul Skingley explains how a Roche managed laboratory service partnership can help laboratories deliver the ideals incorporated in the recent reviews of pathology services in England.

Pathology laboratories in England provide a comprehensive range of services to NHS trusts and local primary care establishments, with in excess of 250 NHS hospitals providing laboratory services to patients all day, every day. In 2006, as part of the NHS Modernisation Programme, Lord Carter was asked by the Labour government to carry out a thorough and systematic evaluation of pathology and laboratory medicine services in England. Now, Roche has responded and can offer a managed laboratory service partnership that can help laboratories deliver the best possible service.

There has never been a more challenging environment than today’s ever-changing, commission-led NHS. The Carter review defined the scope of laboratories in England, showing them as the backbone to the hospital. It has been estimated that 70–80%of all healthcare diagnoses and decisions on treatment are directly influenced by pathology laboratory test results. The necessity and importance of the services delivered by the laboratories is clear, but the costs of these services were rising alarmingly. A managed laboratory service (MLS) partnership can improve efficiency, contain costs and provide flexibility for the future. However, it is essential to choose an experienced managed laboratory partner because experience really can make all the difference.

As the leading company in the UK to offer laboratory-specific managed services, Roche is at the forefront of delivering innovative managed laboratory service solutions to the NHS. With over 100 managed laboratory service sites and management of in excess of 200 suppliers across 25,000 product lines, Roche has more experience than any other organisation at delivering the complex requirements of pathology laboratories and point-of-care testing services, cost effectively and with flexibility. Not every pathology managed service agreement is the same; as Roche customers know, it is a business partnership that evolves through shared objectives and where vision goes beyond the black and white of the contract.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024